Skip to main content
. Author manuscript; available in PMC: 2021 Apr 19.
Published in final edited form as: Infect Control Hosp Epidemiol. 2020 Jan 13;41(3):295–301. doi: 10.1017/ice.2019.358

Table 1.

Clostridioides difficile Infection (CDI) Targeted Assessment for Prevention (TAP) Facility Assessment Frequency of Responses From Select Questionsa, Healthcare System TAP Strategy Implementation for CDI Prevention

Question % Never % Rarely % Sometimes % Often % Always % Unknown
Early Detection and Isolation, Appropriate Testing
Are patients with diarrhea of other known causes tested for CDI? 1 5 24 27 19 24
Are patients without diarrhea tested for CDI? 18 33 20 3 2 25
Are patients tested for CDI cure? 10 8 12 9 7 54
Does your facility allow nurses to order C. difficile testing on patients with suspected CDI without a physician order (eg, through a nurse-driven protocol or standing order)? 21 4 4 11 20 41
Antibiotic Stewardship
Do ordering providers document in the medical record or during order entry a dose, duration, and indication for all antimicrobials at your facility? 0 2 9 24 31 35
In your facility, is it routine practice for specified antimicrobial agents to be approved by a physician or pharmacist at or soon after prescription (eg, preauthorization)? 1 2 3 17 36 42
Does your facility have a formal procedure for all ordering providers to review the appropriateness of all antibiotics at or after 48 h from the initial orders (eg, antibiotic time-out, postprescription review)? 1 2 3 12 30 52
Does your facility review current antibiotics for appropriateness in patients with new or recent CDI diagnosis? 0 1 4 15 36 43
Does your facility monitor antibiotic use (consumption) at the unit and/or facility level? 0 1 4 14 37 43
a

Select questions identified based on the following response frequency thresholds: >33% ‘Unknown’ or > 50% unfavorable responses (ie, sum of ‘Never,’ ‘Rarely,’ ‘Sometimes,’ and ‘Unknown’ or sum of ‘Sometimes,’ ‘Often,’ ‘Always,’ and ‘Unknown’ based on question directionality).